Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
Adult
Antiviral Agents
/ administration & dosage
Athletes
Athletic Performance
Bicycling
Common Cold
Drug Administration Schedule
Female
Glycerol
/ administration & dosage
Health Surveys
Humans
Incidence
Male
Medication Adherence
Oral Sprays
Physical Conditioning, Human
/ statistics & numerical data
Physical Endurance
Prospective Studies
Respiratory Tract Infections
/ drug therapy
Running
Self Report
Severity of Illness Index
Swimming
Time Factors
Trypsin
/ administration & dosage
Virus Diseases
/ drug therapy
Common cold
countermeasure
exercise
illness
immunology
training
Journal
European journal of sport science
ISSN: 1536-7290
Titre abrégé: Eur J Sport Sci
Pays: England
ID NLM: 101146739
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
pubmed:
19
5
2020
medline:
27
7
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
Upper respiratory tract infection (URTI) can compromise athlete preparation and performance, so countermeasures are desirable. The aim of this study was to assess the effects of ColdZyme® Mouth Spray (ColdZyme) on self-reported upper respiratory tract infection in competitive endurance athletes under free-living conditions. One hundred and twenty-three endurance-trained, competitive athletes (recruited across 4 sites in England, UK) were randomised to control (no treatment,
Identifiants
pubmed: 32419645
doi: 10.1080/17461391.2020.1771429
doi:
Substances chimiques
Antiviral Agents
0
Oral Sprays
0
Trypsin
EC 3.4.21.4
Glycerol
PDC6A3C0OX
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM